Kmt2a-rearranged Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Kmt2a-rearranged Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Ziftomenib Maintenance Post Allo-HCT [Phase 1]
A Phase 1 trial evaluating Ziftomenib as maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia (…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy [Phase 2]
This clinical trial update reports a Phase 2 study of ziftomenib for patients with NPM1-mutated or KMT2A-rearranged acute myeloid leukemia w…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML [Phase 1]
A Phase 1 trial evaluating the combination of ziftomenib and mezigdomide in adolescents and adults with relapsed or refractory acute myeloid…